Fox Business - The Power to Prosper
Search Site

Wednesday, April 7, 2010 as of 11:14 AM ET

IMS Health

    IMS Health is a global company that provides information, services and technology for the healthcare industry.

    Read More at Wikipedia ›

    Related Topics

    1. Dow Jones
    2. Health Net
    3. Cardinal Health
    4. Watson Pharmaceuticals
    5. Pfizer
    6. Wyeth
    Get updates on IMS Health
    Lupin Launches Copy Of Geodon Schizophrenia Drug In US

    Lupin Ltd.

    (500257.BY) said Monday a unit has launched ziprasidone hydrochloride, a generic version of Pfizer Inc.'s (PFE) Geodon capsules for treating schizophrenia, in the U.S. after getting final approval from the country's drug regulator.Lupin Pharmaceuticals Inc. received final approval to make and sell ziprasidone hydrochloride capsules in 20 milligram, 40 mg, 60 mg and 80 mg strengths from the U.S. Food and Drug Administration , the Indian generic drug maker said in a statement.Geodon capsules had annual sales of $1.35 billion as per IMS Health data for December 2011.Lupin, being one of the first generic applicants for Geodon, is entitled to share sales exclusivity on the 20 mg-80 mg strengths of the drug, it said.Under U.S. federal law, the first successful generic challenger for a branded drug is awarded 180 days of sales exclusivity.Another Indian generic drug maker, Dr. Reddy's Laboratories Ltd. (500124.BY), had said Saturday it launched generic Geodon.Copyright © 2012 Dow J...

    Read More ›

    1. Glenmark: Unit Gets FDA OK To Sell Generic Malaria Drug

      BANGALORE -(Dow Jones)- Glenmark Pharmaceuticals Ltd. (532296.BY) Wednesday said its generic drugs unit has received final approval from the U.S. Food and Drug Admin...

    2. Lupin: Unit Gets FDA OK To Sell Generic Osteoarthritis Drug

      BANGALORE -(Dow Jones)- Lupin Ltd. (500257.BY) Friday said its U.S unit has received final approval from the U.S. Food and Drug Administration to sell its generic ve...

    3. CPPIB buys Canada toll road stake from Ferrovial

      (Recasts with analyst comment)By Sarah Morris and Cameron FrenchMADRID/TORONTO (Reuters) - Canada's biggest pension manager is spending nearly $900 million to raise ...

    4. Making Money From a Sound Night's Sleep

      Somaxon CEO Richard Pascoe on the company's new product and how it plans to compete in the sleep-aid market.

    5. CPPIB assets rise but investment value shrinks

      TORONTO (Reuters) - Canada Pension Plan Investment Board, the manager of the country's national pension fund, said on Wednesday assets under management edged up in i...

    6. Gold: Is it Really a Safe Haven?

      We break down if the precious metal is a safe play for your portfolio.

    7. Bet on Higher Rates

      Cody sounds off on how you can make money with the dollar and gold.

    1. FDA Cautions Statin Users on Side Effects

      U.S. health regulators are adding warnings to the labels of widely used cholesterol lowering drugs, such as Lipitor, to say they may raise levels of blood sugar and ...

    2. Lupin Settles Patent Dispute Over Glumetza Diabetes Treatment

      Indian generic drug maker Lupin Ltd. (500257.BY) Thursday said it has settled a patent infringement litigation with Santarus Inc. (SNTS) and DepoMed Inc. (DEPO) over...

    3. WellPoint To Cease Branded Lipitor Coverage, Favor Generics

      Health-insurer WellPoint Inc. (WLP) is planning to stop covering Pfizer Inc.'s (PFE) Lipitor cholesterol-lowering pills for millions of members in favor of generic v...

    4. Benefit Manager's Lipitor Move Highlights Pressure On Pfizer

      Pharmacy-benefit manager Express Scripts Inc. (ESRX) will soon make an adjustment that raises out-of-pocket costs for some customers filling prescriptions of Pfizer ...

    5. Diabetes 'Massive Challenge" as Cases Hit 366 Million

      The number of people living with diabetes has soared to 366 million, and the disease kills one person every seven seconds, posing a "massive challenge" to healthcare...

    6. Branded Drug Prices Soar as Generic Pressure Rises

      U.S. prices for brand-name drugs are rising faster than ever as patents expire on top-selling medicines and the pharmaceutical industry nervously eyes the future of ...

    7. Bayer Pharma Teams Up With Cadila To Gain Footing In India

      MUMBAI -(Dow Jones)- Moving to fill a yawning gap in its emerging market strategy, German conglomerate Bayer AG (BAYN.XE) Friday said it formed a joint venture with ...

    Freebase CC-BY
    Source: IMS Health on Freebase, licensed under CC-BY
    Other content from Wikipedia, licensed under the GFDL